直肠内对比剂充盈后腹部超声在严重狭窄性结直肠癌中的价值
回顾性纳入83例因严重肠腔狭窄而结肠镜检查失败的结直肠癌患者,术前2周行直肠内对比剂充盈后腹部超声(AU-TFCA)及增强CT和/或MRI,以术后病理为参考标准。AU-TFCA的T分期与病理一致性(线性加权κ=0.558,p<0.001)优于增强CT/MRI(κ=0.237,p<0.001),T分期总准确率83.1%显著高于增强CT/MRI的50.6%;病变长度AU-TFCA与病理相当(t=1.852,p=0.068),而增强CT/MRI与病理差异显著(t=8.450,p<0.001)。
要点
- AU-TFCA的T分期总准确率83.1%,显著高于增强CT/MRI的50.6%。
- AU-TFCA的T分期与病理一致性线性加权κ=0.558(p<0.001),增强CT/MRI为κ=0.237(p<0.001)。
- 病变长度AU-TFCA与病理相当(t=1.852,p=0.068),增强CT/MRI与病理差异显著(t=8.450,p<0.001)。
核心结论
- AU-TFCA可有效评估严重狭窄性结直肠癌病变的长度和T分期,其诊断准确率显著优于增强CT/MRI。
研究设计与样本
- 回顾性研究,纳入83例因严重肠腔狭窄而结肠镜检查失败的结直肠癌患者,术前2周行AU-TFCA及增强CT和/或MRI,以术后病理结果为参考标准。
诊断标准与关键数值
- T分期与术后病理一致性:AU-TFCA线性加权κ=0.558(p<0.001),增强CT/MRI线性加权κ=0.237(p<0.001)。
- T分期总诊断准确率:AU-TFCA 83.1%,增强CT/MRI 50.6%,AU-TFCA显著高于增强CT/MRI。
- 病变长度与病理比较:AU-TFCA与病理相当(t=1.852,p=0.068),增强CT/MRI与病理差异显著(t=8.450,p<0.001)。
临床应用与阅片要点
- 对因严重肠腔狭窄而结肠镜检查失败的结直肠癌患者,可考虑采用AU-TFCA评估T分期和病变长度。
- AU-TFCA的T分期诊断准确率(83.1%)显著高于增强CT/MRI(50.6%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Abdominal ultrasonography after transrectal filling with contrast agent (AU-TFCA) was retrospectively evaluated with respect to determination of T stage and lesion length in patients with colorectal cancer (CRC) who had previously failed colonoscopy because of severe intestinal stenosis.
METHODS: The population comprised 83 patients with CRC with intestinal stenosis and previously failed colonoscopy who underwent AU-TFCA, and in addition contrast-enhanced computed tomography (CECT) and/or magnetic resonance imaging (MRI), 2 wk before surgery. The diagnostic performance of AU-TFCA and CECT/MRI was evaluated relative to the post-operative pathological results (PPRs) by paired sample t-test, receiver operator characteristic (ROC) curve, Pearson's χ2-test and κ and intraclass correlation coefficients.
RESULTS: The T staging identified via AU-TFCA, but not CECT/MRI, was relatively consistent with that of the PPRs (linearly weighted κ coefficient: 0.558, p < 0.001, and linearly weighted κ coefficient: 0.237, p < 0.001, respectively). The overall diagnostic accuracy of T staging based on AU-TFCA (83.1%) was significantly higher than that based on CECT/MRI (50.6%). Regarding lesion length, the results of AU-TFCA and PPRs were comparable (t = 1.852, p = 0.068), but those of CECT/MRI and PPRs were significantly different (t = 8.450, p < 0.001).
CONCLUSION: AU-TFCA is effective in evaluation of lesion length and T stage in patients with severely stenotic CRC lesions who previously failed colonoscopy. The diagnostic accuracy of AU-TFCA is significantly better compared with that of CECT/MRI.
引用
- Zhong Y, Jian GL, Li QX, et al. Abdominal Ultrasonography After Transrectal Filling With Contrast Agents in Colorectal Cancer With Severely Stenotic Lesions. Ultrasound Med Biol. 2023. PMID: 37423829. doi:10.1016/j.ultrasmedbio.2023.06.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。